• Something wrong with this record ?

Whole genome sequencing of a clinical drug resistant Candida albicans isolate reveals known and novel mutations in genes involved in resistance acquisition mechanisms

RA. Khalaf, N. Fattouh, M. Medvecky, J. Hrabak

. 2021 ; 70 (4) : . [pub] -

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21018928

Candida albicans is an opportunistic pathogen accounting for the majority of cases of Candida infections. Currently, C. albicans are developing resistance towards different classes of antifungal drugs and this has become a global health burden that does not spare Lebanon. This study aims at determining point mutations in genes known to be involved in resistance acquisition and correlating resistance to virulence and ergosterol content in the azole resistant C. albicans isolate CA77 from Lebanon. This pilot study is the first of its kind to be implemented in Lebanon. We carried out whole genome sequencing of the azole resistant C. albicans isolate CA77 and examined 18 genes involved in antifungal resistance. To correlate genotype to phenotype, we evaluated the virulence potential of this isolate by injecting it into BALB/c mice and we quantified membrane ergosterol. Whole genome sequencing revealed that eight out of 18 genes involved in antifungal resistance were mutated in previously reported and novel residues. These genotypic changes were associated with an increase in ergosterol content but no discrepancy in virulence potential was observed between our isolate and the susceptible C. albicans control strain SC5314. This suggests that antifungal resistance and virulence potential in this antifungal resistant isolate are not correlated and that resistance is a result of an increase in membrane ergosterol content and the occurrence of point mutations in genes involved in the ergosterol biosynthesis pathway.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018928
003      
CZ-PrNML
005      
20210830100514.0
007      
ta
008      
210728s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1099/jmm.0.001351 $2 doi
035    __
$a (PubMed)33909551
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Khalaf, Roy A $u Department of Natural Sciences, Lebanese American University, PO Box 36, Byblos, Lebanon
245    10
$a Whole genome sequencing of a clinical drug resistant Candida albicans isolate reveals known and novel mutations in genes involved in resistance acquisition mechanisms / $c RA. Khalaf, N. Fattouh, M. Medvecky, J. Hrabak
520    9_
$a Candida albicans is an opportunistic pathogen accounting for the majority of cases of Candida infections. Currently, C. albicans are developing resistance towards different classes of antifungal drugs and this has become a global health burden that does not spare Lebanon. This study aims at determining point mutations in genes known to be involved in resistance acquisition and correlating resistance to virulence and ergosterol content in the azole resistant C. albicans isolate CA77 from Lebanon. This pilot study is the first of its kind to be implemented in Lebanon. We carried out whole genome sequencing of the azole resistant C. albicans isolate CA77 and examined 18 genes involved in antifungal resistance. To correlate genotype to phenotype, we evaluated the virulence potential of this isolate by injecting it into BALB/c mice and we quantified membrane ergosterol. Whole genome sequencing revealed that eight out of 18 genes involved in antifungal resistance were mutated in previously reported and novel residues. These genotypic changes were associated with an increase in ergosterol content but no discrepancy in virulence potential was observed between our isolate and the susceptible C. albicans control strain SC5314. This suggests that antifungal resistance and virulence potential in this antifungal resistant isolate are not correlated and that resistance is a result of an increase in membrane ergosterol content and the occurrence of point mutations in genes involved in the ergosterol biosynthesis pathway.
650    _2
$a zvířata $7 D000818
650    _2
$a azoly $x farmakologie $7 D001393
650    _2
$a Candida albicans $x chemie $x účinky léků $x genetika $x patogenita $7 D002176
650    _2
$a fungální léková rezistence $x genetika $7 D025141
650    _2
$a ergosterol $x analýza $7 D004875
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a fenotyp $7 D010641
650    _2
$a pilotní projekty $7 D010865
650    _2
$a bodová mutace $7 D017354
650    _2
$a virulence $7 D014774
650    12
$a sekvenování celého genomu $7 D000073336
651    _2
$a Libanon $7 D007861
655    _2
$a časopisecké články $7 D016428
700    1_
$a Fattouh, Nour $u Department of Natural Sciences, Lebanese American University, PO Box 36, Byblos, Lebanon
700    1_
$a Medvecky, Matej $u Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK
700    1_
$a Hrabak, Jaroslav $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic $u Department of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, 32300 Pilsen, Czech Republic
773    0_
$w MED00002792 $t Journal of medical microbiology $x 1473-5644 $g Roč. 70, č. 4 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33909551 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100515 $b ABA008
999    __
$a ok $b bmc $g 1689882 $s 1139374
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 70 $c 4 $e - $i 1473-5644 $m Journal of Medical Microbiology $n J Med Microbiol $x MED00002792
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Archiving options